TDC
MDT icon

Thompson Davis & Co’s Medtronic MDT Stock Holding History

Thompson Davis & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-768
Closed -$60K – 909
2017
Q3 		$60K Buy
768
+20
+3% +$1.66K 0.11% 200
2017
Q2 		$66K Buy
748
+296
+65% +$25K 0.11% 181
2017
Q1 		$36K Buy
452
+100
+28% +$7.81K 0.05% 310
2016
Q4 		$25K Buy
352
+13
+4% +$1.02K 0.04% 416
2016
Q3 		$29K Sell
339
-55
-14% -$4.79K 0.05% 356
2016
Q2 		$34K Buy
394
+30
+8% +$2.43K 0.05% 311
2016
Q1 		$27K Sell
364
-3,150
-90% -$237K 0.04% 362
2015
Q4 		$270K Buy
3,514
+3,150
+865% +$237K 0.38% 63
2015
Q3 		$24K Buy
364
+80
+28% +$5.89K 0.03% 413
2015
Q2 		$21K Hold
284
– – 0.02% 527
2015
Q1 		$22K Buy
+284
New +$21.5K 0.03% 508
2014
Q4 		– Sell
-146
Closed -$9K – 1221
2014
Q3 		$9K Buy
+146
New +$9.28K 0.01% 728

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Thompson Davis & Co's MDT Position: Q4 2017 in Review

Thompson Davis & Co sold out of Medtronic (MDT) in Q4 2017, closing a stake of 768 shares — an estimated $60K sold.

Thompson Davis & Co first reported a position in MDT in Q3 2014 and held it in 12 quarters. The position peaked at $270K in Q4 2015. 1,408 funds tracked by Wall St. Rank hold MDT as of Q4 2017.

  • Thompson Davis & Co reported no remaining Medtronic position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 768 Medtronic shares in Q4 2017, an estimated $60K.
  • Thompson Davis & Co first reported a position in Medtronic in Q3 2014 and held it in 12 quarters.
  • Thompson Davis & Co's Medtronic position peaked at $270K in Q4 2015.
  • 1,408 funds tracked by Wall St. Rank held Medtronic as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.